S03 E04
Surgibots Podcast

The Biggest Competition for Surgical Robotics Companies - Bjoern von Siemens - Caresyntax

Explore the complexity of clinical data with Bjoern von Siemens, the Founder of Caresyntax and this week’s guest speaker. In this episode, hosted by Henry Norton, Bjoern discussed the future of MedTech, including the role that data and AI will play in developing the technology that is currently set to transform surgery for future generations. They also touched on the importance of reducing the cost of care and making safe surgery accessible to everyone. Tune in to learn more about the role of automation and analytics in developing the surgical robotics industry.

The Biggest Competition for Surgical Robotics Companies - Bjoern von Siemens - Caresyntax

ALSO AVAILABLE ON

SpotifyApple podcastsAmazon music
Share
S04 E04

The Biggest Competition for Surgical Robotics Companies - Bjoern von Siemens - Caresyntax

 

The Future of Surgical Robotics: Insights from Bjoern von Siemens

Surgical Robotics and Data Integration: A New Era of Precision Medicine

The intersection of surgical robotics, AI, and data aggregation is shaping the future of medtech. In a recent Surgibots podcast episode, Bjoern von Siemens, co-founder of CareSyntax, shared his insights on how data-driven technologies are transforming surgery and why precision medicine is the future of healthcare.

The Competitive Landscape in Surgical Robotics

One of the most striking takeaways from the conversation was Siemens’ assertion that the biggest competition in surgical robotics may not necessarily be another robotics company—but rather those who aggregate and utilize surgical data effectively.

"Companies best positioned to capture clinical information—data on patients and the entire episode of care—will ultimately be able to create the most effective therapies and devices," Siemens explained.

This highlights a shift in competition: from just developing advanced robotic systems to owning and leveraging high-fidelity surgical data.

The Role of AI in Surgical Innovation

CareSyntax has been at the forefront of integrating AI into surgical workflows. Siemens shared that when the company was founded over a decade ago, AI in surgery was met with skepticism. Today, AI-driven automation is increasingly recognized as essential to optimizing surgical processes.

Early applications of AI in surgery have included:

  • Automating operating room setup
  • Providing real-time surgical insights
  • Predicting post-operative complications
  • Enhancing workflow efficiency with predictive analytics

The ability to reduce risk factors and improve patient outcomes through AI is now a critical driver for hospitals and medtech companies alike.

Overcoming Challenges in Surgical Automation

While the benefits of automation in surgery are clear, Siemens pointed out key roadblocks to its widespread adoption:

  • Financial Barriers: Many hospitals struggle to secure funding for new technologies, with limited reimbursement models available for AI-driven surgical assistance.
  • Regulatory Challenges: AI-driven decision-making must be rigorously tested and validated before it can be widely implemented.
  • Cultural Adoption: Many healthcare professionals have been burned by inefficient digital solutions in the past, leading to skepticism about new technologies.
  • Competitive Dynamics: Medtech incumbents may resist changes that disrupt traditional device sales models.

Overcoming these challenges requires a combination of better funding models, stronger regulatory frameworks, and clearer evidence of improved surgical outcomes.

The Future of Surgical Robotics

Looking ahead, Siemens envisions a future where digital workflows and AI-powered guidance become essential components of every surgical procedure. Some key predictions include:

  • Mass Adoption of Surgical Robotics: As technology advances and costs decline, robotic-assisted surgery will become the norm across multiple disciplines.
  • Increased Focus on Digital Platforms: Robotics will no longer be just about hardware—successful systems will integrate software solutions that provide real-time guidance and optimize workflows.
  • More Accessible Surgery: While today’s robotic platforms are largely confined to premium markets, future iterations—especially from emerging markets like China and India—will make surgical robotics more affordable and globally available.
  • The Role of Data Aggregators: Companies like CareSyntax are poised to play a crucial role in transforming surgical outcomes by providing AI-driven insights based on high-fidelity surgical data.

Final Thoughts

The medtech landscape is rapidly evolving, and surgical robotics is at the forefront of this transformation. As AI and data-driven insights become more deeply integrated into surgical procedures, the next decade will likely see unprecedented advancements in precision medicine and patient outcomes.

CareSyntax is positioning itself as a key enabler in this space, ensuring that the right technologies are deployed to create safer, more efficient, and more personalized surgical care.

For those interested in the latest developments in surgical robotics and medtech innovation, the Surgibots podcast provides invaluable insights from industry pioneers shaping the future of healthcare.

LISTEN ON YOUR FAVOURITE PODCAST PLATFORM
SpotifyApple podcastsAmazon music

More episodes in this industry

What's the Hype with Neuro? A Lesson in the Brain - With Hannah Claridge
Podcast43

What's the Hype with Neuro? A Lesson in the Brain - With Hannah Claridge

In this episode, your host, Henry Norton, is joined by Hannah Claridge, the Head of Neurotechnology at TTP, to talk about the incredible advancements that are being made to treat neurological conditions. Hannah points out how complex the brain and nervous systems are, with both relying on intricate connections. She also explores the new technologies that are being developed to treat nervous disorders, such as spinal cord stimulation. She also compared neurotechnologies to pharmaceuticals, highlighting the parallels and differences in how they interact with the body. Hannah also suggested that neurotherapy will be key to the advancement of treatments for conditions like depression, due to their ability to provide targeted and long-term relief of symptoms. Cybersecurity is also a major concern for neurotechnology, as any malfunction or deliberate interference could have serious ramifications for patients.
Why Most Medtech Fundraisers Fail and What to Do Instead - Kiko Filipov, Partner at APPARIUS
Podcast42

Why Most Medtech Fundraisers Fail and What to Do Instead - Kiko Filipov, Partner at APPARIUS

Raising capital in Medtech is tougher than ever. Investor expectations have shifted. Competition is up. And many founders are still pitching like it’s 2018. In this episode, Henry Norton sits down with Kiko Filipov, Partner at APPARIUS Corporate Finance and Strategic Advisor at Cruxx, to unpack the real mechanics of a successful fundraise in 2025. From first-in-human data to commercial readiness, Kiko shares what separates the rounds that get oversubscribed from the ones that stall. He also explores the changing landscape of Medtech innovation and why strategic exits take years of planning, how emerging markets are joining the race, and where VCs are placing bets across surgical robotics, neurostimulation, and digital health. Whether you're gearing up for Series A or preparing your pitch deck, this episode delivers tactical clarity from someone who’s in the room with both founders and funds.

Discover more about Medical Devices